This rapid expansion in use (with nearly 12% of Americans now having tried GLP-1 medications) has brought with it concerning reports of severe side effects that manufacturers allegedly failed to adequately disclose, forming the basis of thousands of lawsuits now consolidated in federal court
This gut-soothing medication works directly where its needed to calm nausea caused by new medications, morning-after hangovers, unfamiliar foods, or travel adventures
GLP-1 users saw a 44% reduction in hospitalizations due to stroke, heart attack and heart failure compared to the control group
Patient safety recommendations include: Never purchase peptides from unregulated online sources or unlicensed 'wellness' clinics Discuss any interest in peptide therapy with your GP or hepatologist Ensure any prescribed peptides are obtained through legitimate NHS or registered pharmacy channels Report suspected side effects via the MHRA Yellow Card Scheme at Prioritise evidence-based lifestyle modifications as first-line management Patients experiencing symptoms suggestive of liver disease progressionsuch as jaundice (yellowing of skin or eyes), abdominal swelling, confusion, or bleeding tendenciesshould seek urgent medical attention
The most common side effects of Zepbound are gastrointestinal, including nausea (29-33% of patients), diarrhea (21-23%), constipation (17-19%), vomiting (10-13%), abdominal pain, and dyspepsia
By modulating these pathways, GLP-1s can reduce cravings for both food and other substances, such as alcohol